Jazz Pharmaceuticals plc — Director's Dealing 2022

Nov 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-11-16

Reporting Person: Patil Neena M (EVP & Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-16	Ordinary Shares	S	3510	$142.34	Disposed	26769	Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $142.28 to $142.50. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.